MVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.
Portfolio 18
| Date | Name | Website | Total Raised | Location |
| 17.03.2021 | eXmoor Pha... | exmoorphar... | $35M | United Sta... |
| 25.11.2020 | GT medical... | gtmedtech.... | $74.4M | United Sta... |
| - | Woodcast | woodcast.f... | - | - |
| - | Patient Co... | patientcon... | - | United Kin... |
| - | Alliance P... | allianceph... | - | United Kin... |
| - | Vertos Med... | vertosmed.... | $54M | United Sta... |
| - | eZono | ezono.com | $10M | Germany, T... |
| - | Biotherano... | biotherano... | $32M | United Sta... |
| - | SkyCell AG | skycell.ch | $155.67M | Switzerlan... |
| - | Valneva | valneva.co... | $112M | France, Pa... |
Show more
News 16
| Date | Title | Description |
| 17.03.2021 | MVM invests in eXmoor Pharma | eXmoor, the expert cell and gene therapy (CGT) services company (Bristol, England), has announced an... |
| 04.03.2021 | Hologic announces acquisition of Biotheranostics | Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed ... |
| 05.01.2021 | MVM Winter 2020 Newsletter | Winter 2020 Newsletter _________________________________________________ MVM team news MVM invests... |
| 25.11.2020 | MVM invests in GT Medical | GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tum... |
| 15.09.2020 | Valneva announces major COVID-19 vaccine partnership with UK... | - UK Government has secured supply of 60 million doses at a cost of €470 million with options over a... |
| 10.09.2020 | MVM Summer 2020 Newsletter | Summer 2020 Newsletter ________________________________________ MVM team news MVM invests in MDxHe... |
| - | HLS Therapeutics announces Health Canada approval for Vascep... | • Health Canada approval follows priority review for Vascepa • Vascepa becomes the first and only HC... |
| - | Valneva confirms participation in UK government COVID-19 vac... | Valneva SE, a specialty vaccine company focused on prevention against diseases with major unmet need... |
| - | MVM invests in MDxHealth SA | In May 2020, MVM closed a growth investment in MDxHealth SA, a company that markets proprietary, dif... |
| - | HLS Therapeutics announces Health Canada grants medical devi... | - From a single drop of blood from the tip of a finger, Athelas One WBC System generates white blood... |
Show more
Mentions in press and media 10
| Date | Title | Description | Source |
| 26.01.2024 | Global healthcare VC firm invests $30m in icotec | Based in Altstätten (St. Gallen ), icotec develops and produces carbon-fiber-reinforced implants fo... | startuptic... |
| 11.02.2022 | Amsterdam-based Life Science Partners closes €1B funding for... | Life Science Partners (LSP), an Amsterdam-based investment firm that provides finance for life scien... | siliconcan... |
| 11.02.2022 | As it prepares to join EQT, Life Science Partners surpasses ... | Just a few months ago, the European investment firm Life Science Partners announced that it would be... | endpts.com... |
| 28.04.2020 | SkyCell receives CHF 62 million growth financing | startuptic... | |
| 28.04.2020 | SkyCell receives CHF 62 million growth financing | SkyCell, the Swiss developer of data-driven, temperature-controlled containers for the pharmaceutica... | startuptic... |
| 13.08.2018 | Accelerator Life Science Partners Launches Magnolia Neurosci... | NEW YORK--(BUSINESS WIRE)--Accelerator Life Science Partners, a leading life science investment and ... | citybizlis... |
| 13.08.2018 | Accelerator Life Science Partners Launches Magnolia Neurosci... | - | jnjinnovat... |
| 04.05.2016 | MVM Life Science Partners closes largest raise to date | The funding firm MVM Life Science Partners, which is behind the creation and development of a number... | fiercebiot... |
| 03.05.2016 | MVM Life Science Partners LLP closes MVM IV at $233 million | LONDON & BOSTON–(BUSINESS WIRE)–May 3, 2016– MVM Life Science Partners today announced the closi... | venturebea... |
| 17.04.2014 | Wilson Therapeutics Receives $40M in Series B Funding | Wilson Therapeutics, a Stockholm, Sweden-based biopharmaceutical company, received $40m in Series B ... | finsmes.co... |